PLA2G4C
Cytosolic phospholipase A2 gamma
Also known as: cPLA2-gamma, PA24C_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UP65
- Gene
- PLA2G4C
- Ensembl
- ENSG00000105499
- Chromosome
- 19
- Canonical length
- 541 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a protein which is a member of the phospholipase A2 enzyme family which hydrolyzes glycerophospholipids to produce free fatty acids and lysophospholipids, both of which serve as precursors in the production of signaling molecules. The encoded protein has been shown to be a calcium-independent and membrane bound enzyme. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2009]
Canonical amino-acid sequenceUniProt
541 residues, UniProt reviewed canonical sequence.
>Q9UP65|PLA2G4C
1 MGSSEVSIIP GLQKEEKAAV ERRRLHVLKA LKKLRIEADE APVVAVLGSG GGLRAHIACL
61 GVLSEMKEQG LLDAVTYLAG VSGSTWAISS LYTNDGDMEA LEADLKHRFT RQEWDLAKSL
121 QKTIQAARSE NYSLTDFWAY MVISKQTREL PESHLSNMKK PVEEGTLPYP IFAAIDNDLQ
181 PSWQEARAPE TWFEFTPHHA GFSALGAFVS ITHFGSKFKK GRLVRTHPER DLTFLRGLWG
241 SALGNTEVIR EYIFDQLRNL TLKGLWRRAV ANAKSIGHLI FARLLRLQES SQGEHPPPED
301 EGGEPEHTWL TEMLENWTRT SLEKQEQPHE DPERKGSLSN LMDFVKKTGI CASKWEWGTT
361 HNFLYKHGGI RDKIMSSRKH LHLVDAGLAI NTPFPLVLPP TREVHLILSF DFSAGDPFET
421 IRATTDYCRR HKIPFPQVEE AELDLWSKAP ASCYILKGET GPVVMHFPLF NIDACGGDIE
481 AWSDTYDTFK LADTYTLDVV VLLLALAKKN VRENKKKILR ELMNVAGLYY PKDSARSCCL
541 ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLA2G4C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 73 nTPM
Expression across tissuesHPA
Tissue
- retina: 73 nTPM
- skeletal muscle: 63 nTPM
- tongue: 38 nTPM
- heart muscle: 24 nTPM
- spinal cord: 19 nTPM
- midbrain: 19 nTPM
Single-cell type
- myonuclei: 462 nCPM
- rod photoreceptor cells: 289 nCPM
- retinal bipolar cells: 178 nCPM
- bergmann glia: 176 nCPM
- oligodendrocytes: 153 nCPM
- pancreatic duct cells: 122 nCPM
Immune cell
- intermediate monocyte: 5.8 nTPM
- memory B-cell: 4.1 nTPM
- classical monocyte: 2.1 nTPM
- non-classical monocyte: 1.4 nTPM
- total PBMC: 1.4 nTPM
- myeloid DC: 1.2 nTPM
Brain region
- white matter: 87 nTPM
- pons: 57 nTPM
- medulla oblongata: 53 nTPM
- midbrain: 50 nTPM
- basal ganglia: 50 nTPM
- cerebral cortex: 47 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.17
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- arachidonate metabolic process
- glycerophospholipid catabolic process
- inflammatory response
- intracellular signal transduction
- lipid droplet formation
- parturition
- phosphatidylcholine acyl-chain remodeling
- phosphatidylethanolamine acyl-chain remodeling
- phospholipid metabolic process
- platelet activating factor biosynthetic process
Molecular functions
- calcium ion binding
- calcium-dependent phospholipase A2 activity
- calcium-dependent phospholipid binding
- calcium-independent phospholipase A2 activity
- O-acyltransferase activity
- phosphatidylcholine lysophospholipase activity
- phospholipase A1 activity
- phospholipid binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLA2G4C as an antibody target. Whether an autoantibody or antibody against PLA2G4C could matter depends on whether native PLA2G4C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLA2G4C is annotated at the cell surface, where native PLA2G4C is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PLA2G4C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...